AaronRosenbergMD

PubMed

• Survival after diffuse large B-cell lymphoma among children, adolescents, and young adults in California, 2001-2014: A population-based study.
  Abrahão, R.,Ribeiro, R. C.,Lichtensztajn, D. Y.,Rosenberg, A. S.,Keegan, THM.> ;Pediatr Blood Cancer. 2018 Dec 05
• Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
  Keegan THM, Bleyer A, Rosenberg AS, Li Q, Goldfarb M> ;JAMA oncology.
• Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia.
  Pon, T. K.,Mahajan, A.,Rosenberg, A.,Amin, A.,Shah, D.,Jenkins, I.,Gupta, V.,Hofmann, H.,Bejjani, A.,White, R.> ;J. Thromb. Thrombolysis. 2018 Mar 27
• Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.
  Ho, G.,Wun, T.,Muffly, L.,Li, Q.,Brunson, A.,Rosenberg, A. S.,Jonas, B. A.,Keegan, THM.> ;Cancer. 2018 Feb 17
• Assessing the Effect of Adherence on Patient-reported Outcomes and Out of Pocket Costs Among Patients With Multiple Myeloma.
  Gupta S, Abouzaid S, Liebert R, Parikh K, Ung B, Rosenberg AS> ;Clinical lymphoma, myeloma & leukemia. 2018-01-31
• Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
  Goldfarb, M.,Rosenberg, A. S.,Li, Q.,Keegan, THM.> ;Cancer. 2017 Dec 06
• Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance.
  Rosenberg AS, Brunson A, Paulus JK, Tuscano J, Wun T, Keegan THM, Jonas BA> ;Blood cancer journal. 2017-09-08
• Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era.
  Tao L, Clarke CA, Rosenberg AS, Advani RH, Jonas BA, Flowers CR, Keegan THM> ;British journal of haematology. 2017-05-25
• Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.
  Brunson A, Lei A, Rosenberg AS, White RH, Keegan T, Wun T> ;British journal of haematology. 2017-04-03
• 1 citation
  Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.
  Rosenberg, A. S., Ruthazer, R., Paulus, J. K., Kent, D. M., Evens, A. M., Klein, A. K.> ;Clinical lymphoma, myeloma & leukemia. 2016 Oct 25
• Investigation into the interference of the monoclonal antibody daratumumab on the free light chain assay.
  Rosenberg AS, Bainbridge S, Pahwa R, Jialal I> ;Clin Biochem. 2016 Jul 28
• Breast cancer and thrombosis: timing matters.
  Paulus JK, Rosenberg AS> ;Blood. 2016 Feb 18
• Incidence and evaluation of incidental abnormal bone marrow signal on magnetic resonance imaging.
  Shah GL, Rosenberg AS, Jarboe J, Klein A, Cossor F> ;TheScientificWorldJournal. 2014-10-14
• Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor.
  Rosenberg A Mathew P > ;Expert Opin Investig Drugs . 2013 Apr 1
• Join now to see all

Abstracts/Posters

• Blinatumomab/Lenalidomide in Relapsed/Refractory Non-HodgkinÍs Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative Analysis
  Aaron Seth Rosenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phase I Study of Escalating Doses of Carfilzomib with Hyper-CVAD in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
  Aaron Seth Rosenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019